FDA authorization covers platinum-resistant disease after 1–3 prior lines, with mandatory prior bevacizumab exposure, ...

FDA approval of Lifyorli plus nab-paclitaxel offers a new option for platinum-resistant epithelial ovarian cancer after 1 to 3 prior systemic regimens.

The approval is based on the results of Corcept’s Phase 3 ROSELLA trial, which showed improvements in both progression-free survival and overall survival. ・The approval covers adults with ...

Removing fallopian tubes, a procedure known as opportunistic salpingectomy, may help prevent the development of ovarian cancer, according to a consensus statement from the Ovarian Cancer Research ...

“Knowledge is power,” says Samantha Carlucci, 26. The Ravena, New York, resident recently had a hysterectomy that included removing her fallopian tubes – and believes it saved her life. The Ovarian ...

Removing fallopian tubes, a procedure known as opportunistic salpingectomy, may help reduce the risk of developing ovarian cancer, according to a consensus statement from the Ovarian Cancer Research ...

Because there is no effective screening method to catch ovarian cancer at an early stage, most diagnoses occur when the cancer has reached its later stages. As a result, only about half of women with ...

Add Yahoo as a preferred source to see more of our stories on Google. The surgery to remove both fallopian tubes is called a bilateral salpingectomy. (Getty Images) (SvetaZi via Getty Images) Ovarian ...

Shares of Corcept Therapeutics (NASDAQ:CORT) surged about 40% on Wednesday after the U.S. Food and Drug Administration (FDA) ...

The new guidance from the Ovarian Cancer Research Alliance comes after the organization found that early screening and detection attempts were not effective in preventing deaths The Ovarian Cancer ...

Removing fallopian tubes during sterilization is about as safe as sterilization procedures that damage the tubes but leave them intact, a new study suggests — a finding that could help reduce some ...

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Fallopian Tube Cancer Market - A Global and Regional Analysis: Focus on Type, Treatment Type, End User, and Region, 2025-2035" report has been added to ...